Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TEAD1 | P28347 | 3/20 | 0.45 |
| ▸ | TEAD3 | Q99594 | 1/20 | 0.45 |
| ▸ | JAK3 | P52333 | 3/20 | 0.43 |
| ▸ | EGFR | P00533 | 2/20 | 0.41 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.41 |
| ▸ | FGFR2 | P21802 | 2/20 | 0.41 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.41 |
| ▸ | FGFR3 | P22607 | 1/20 | 0.41 |
| ▸ | BTK | Q06187 | 3/20 | 0.40 |
| ▸ | KRAS | P01116 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24492204 | 1.00 | TEAD1 (0.45) | TEAD1TEAD3JAK3EGFRFGFR1 | |
| SCHEMBL16285101 | 0.92 | TEAD1 (0.49) | TEAD1TEAD3JAK3FGFR1FGFR2 | |
| SCHEMBL16285092 | 0.90 | POLB (0.44) | JAK3EGFRFGFR1FGFR2FGFR3 | |
| SCHEMBL24492424 | 0.88 | JAK3 (0.40) | TEAD1TEAD3JAK3FGFR1FGFR2 | |
| SCHEMBL16285122 | 0.86 | TEAD1 (0.42) | TEAD1TEAD3JAK3EGFRFGFR1 | |
| SCHEMBL17235860 | 0.83 | TEAD1 (0.40) | TEAD1TEAD3JAK3EGFRFGFR1 | |
| SCHEMBL16846933 | 0.83 | TEAD1 (0.43) | TEAD1TEAD3JAK3FGFR1FGFR2 | |
| SCHEMBL11950456 | 0.83 | TEAD1 (0.43) | TEAD1TEAD3JAK3FGFR1FGFR2 | |
| SCHEMBL19240545 | 0.83 | TEAD1 (0.43) | TEAD1TEAD3JAK3FGFR1FGFR2 | |
| SCHEMBL16285084 | 0.83 | TEAD1 (0.42) | TEAD1TEAD3JAK3EGFRFGFR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170137644-A1 | INK, INK CARTRIDGE, INK JET RECORDING DEVICE, INK JET INK PRINTED MATTER, COMPOUND, AND COMPOSITION | MORITA MITSUNOBU (JP) | 2017-05-18 | — | — | US | disclosed |
| US-9593248-B2 | Ink, ink cartridge, ink jet recording device, ink jet ink printed matter, compound, and composition | RICOH COMPANY, LTD. (JP) | 2017-03-14 | — | — | US | disclosed |
| US-20140363634-A1 | INK, INK CARTRIDGE, INK JET RECORDING DEVICE, INK JET INK PRINTED MATTER, COMPOUND, AND COMPOSITION | RICOH COMPANY, LTD. (JP) | 2014-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140363634-A1 | INK, INK CARTRIDGE, INK JET RECORDING DEVICE, INK JET INK PRINTED MATTER, COMPOUND, AND COMPOSITION | CDKN1A, MAPK9, SFRP1 | TEAD1 1473/4885TEAD3 1705/4885JAK3 14/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.